RTA 408, A Novel Synthetic Triterpenoid with Broad Anticancer and Anti-Inflammatory Activity
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
RTA 408, A Novel Synthetic Triterpenoid with Broad Anticancer and Anti-Inflammatory Activity
Authors
Keywords
Cancer treatment, Transcription factors, Apoptosis, Inflammation, Gene expression, Cyclins, Nitric oxide, Antioxidants
Journal
PLoS One
Volume 10, Issue 4, Pages e0122942
Publisher
Public Library of Science (PLoS)
Online
2015-04-22
DOI
10.1371/journal.pone.0122942
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Myeloid Lineage-Specific Deletion of Antioxidant System Enhances Tumor Metastasis
- (2014) K. Hiramoto et al. Cancer Prevention Research
- Preclinical evidences toward the use of triterpenoid CDDO-Me for solid cancer prevention and treatment
- (2014) Yan-Yang Wang et al. Molecular Cancer
- Structure of the BTB Domain of Keap1 and Its Interaction with the Triterpenoid Antagonist CDDO
- (2014) Anne Cleasby et al. PLoS One
- Topical Application of the Synthetic Triterpenoid RTA 408 Protects Mice from Radiation-Induced Dermatitis
- (2014) Scott A. Reisman et al. RADIATION RESEARCH
- Topical application of the synthetic triterpenoid RTA 408 activates Nrf2 and induces cytoprotective genes in rat skin
- (2013) Scott A. Reisman et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- The Synthetic Triterpenoid CDDO-Methyl Ester Delays Estrogen Receptor-Negative Mammary Carcinogenesis in Polyoma Middle T Mice
- (2012) K. Tran et al. Cancer Prevention Research
- Molecular Pathways: Tumor-Infiltrating Myeloid Cells and Reactive Oxygen Species in Regulation of Tumor Microenvironment
- (2012) T. Lu et al. CLINICAL CANCER RESEARCH
- A Phase I First-in-Human Trial of Bardoxolone Methyl in Patients with Advanced Solid Tumors and Lymphomas
- (2012) D. S. Hong et al. CLINICAL CANCER RESEARCH
- The cytoprotective role of the Keap1–Nrf2 pathway
- (2011) Liam Baird et al. ARCHIVES OF TOXICOLOGY
- Nrf2: control of sensitivity to carcinogens
- (2011) Stephen L. Slocum et al. ARCHIVES OF TOXICOLOGY
- The synthetic triterpenoid CDDO-Imidazolide suppresses experimental liver metastasis
- (2011) Jason L. Townson et al. CLINICAL & EXPERIMENTAL METASTASIS
- Novel Function of Transcription Factor Nrf2 as an Inhibitor of RON Tyrosine Kinase Receptor-mediated Cancer Cell Invasion
- (2011) Amalraj Thangasamy et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Genetic Disruption of KEAP1/CUL3 E3 Ubiquitin Ligase Complex Components is a Key Mechanism of NF-KappaB Pathway Activation in Lung Cancer
- (2011) Kelsie L. Thu et al. Journal of Thoracic Oncology
- Gain of Nrf2 Function in Non-Small-Cell Lung Cancer Cells Confers Radioresistance
- (2010) Anju Singh et al. ANTIOXIDANTS & REDOX SIGNALING
- Synthetic Triterpenoids Prolong Survival in a Transgenic Mouse Model of Pancreatic Cancer
- (2010) K. T. Liby et al. Cancer Prevention Research
- Nrf2-deficiency creates a responsive microenvironment for metastasis to the lung
- (2010) Hironori Satoh et al. CARCINOGENESIS
- INrf2 (Keap1) targets Bcl-2 degradation and controls cellular apoptosis
- (2010) S K Niture et al. CELL DEATH AND DIFFERENTIATION
- Anti-inflammatory Triterpenoid Blocks Immune Suppressive Function of MDSCs and Improves Immune Response in Cancer
- (2010) S. Nagaraj et al. CLINICAL CANCER RESEARCH
- Increased cell migration and plasticity in Nrf2-deficient cancer cell lines
- (2010) G Rachakonda et al. ONCOGENE
- Oleanolic acid activates Nrf2 and protects from acetaminophen hepatotoxicity via Nrf2-dependent and Nrf2-independent processes
- (2009) Scott A. Reisman et al. BIOCHEMICAL PHARMACOLOGY
- Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice
- (2009) Melinda S. Yates et al. CARCINOGENESIS
- Nrf2: friend or foe for chemoprevention?
- (2009) T. W. Kensler et al. CARCINOGENESIS
- KEAP1 E3 Ligase-Mediated Downregulation of NF-κB Signaling by Targeting IKKβ
- (2009) Dung-Fang Lee et al. MOLECULAR CELL
- NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer
- (2009) John D. Hayes et al. TRENDS IN BIOCHEMICAL SCIENCES
- Coupling of Endoplasmic Reticulum Stress to CDDO-Me-Induced Up-regulation of Death Receptor 5 via a CHOP-Dependent Mechanism Involving JNK Activation
- (2008) W. Zou et al. CANCER RESEARCH
- Triterpenoid CDDO-Methyl Ester Inhibits the Janus-Activated Kinase-1 (JAK1)->Signal Transducer and Activator of Transcription-3 (STAT3) Pathway by Direct Inhibition of JAK1 and STAT3
- (2008) R. Ahmad et al. CANCER RESEARCH
- Loss of Keap1 Function Activates Nrf2 and Provides Advantages for Lung Cancer Cell Growth
- (2008) T. Ohta et al. CANCER RESEARCH
- Physiological Significance of Reactive Cysteine Residues of Keap1 in Determining Nrf2 Activity
- (2008) T. Yamamoto et al. MOLECULAR AND CELLULAR BIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started